interest
potenti
monoclon
antibodi
mab
serv
therapeut
agent
surg
past
decad
major
emphasi
human
viral
diseas
much
attent
area
direct
toward
human
immunodefici
viru
promis
research
develop
emerg
inhibit
infect
mab
identif
sever
highli
conserv
neutral
epitop
recent
potent
fullyhuman
neutral
mab
develop
varieti
import
human
viral
diseas
agent
includ
paramyxovirus
hendra
viru
nipah
viru
human
human
mab
develop
sever
acut
respiratori
syndrom
coronaviru
sar
cov
west
nile
viru
among
other
recent
develop
antivir
mab
come
use
antibodi
phagedisplay
technolog
implement
simplifi
inexpens
yet
effici
method
express
purifi
initi
select
fragment
antibodi
prime
import
facilit
area
research
interest
potenti
monoclon
antibodi
mab
therapeut
agent
surg
past
decad
current
howev
main
therapeut
target
antibodi
remain
cancer
autoimmun
diseas
one
antibodi
target
viral
infect
synagi
palivizumab
approv
fda
prophylaxi
respiratori
syncyti
viru
recent
potent
neutral
human
monoclon
antibodi
select
emerg
paramyxovirus
hendra
viru
nipah
viru
evalu
vivo
efficaci
ferret
model
newli
discov
human
mab
human
immunodefici
viru
develop
target
highli
conserv
epitop
envelop
glycoprotein
demonstr
affin
human
protein
lipid
addit
human
fulli
human
mab
select
sever
acut
respiratori
syndrom
coronaviru
sar
cov
west
nile
viru
among
other
perhap
among
signific
advanc
facilit
develop
specif
antivir
mab
implement
bacteri
phage
display
platform
use
combinatori
antibodi
librari
phage
librari
prepar
encod
human
antibodi
fragment
antibodi
fab
contain
light
chain
first
two
domain
heavi
chain
meet
increas
research
need
implement
new
method
express
purifi
recombin
antibodi
primari
import
facilit
effici
product
decreas
product
cost
recombin
antibodi
product
method
usual
consist
three
major
step
transform
express
purif
transform
step
plasmid
dna
code
histag
fab
transform
bacteri
cell
success
transform
cell
select
use
ampicillin
step
fab
express
suppress
high
glucos
concentr
medium
next
step
isopropyl
iptg
absenc
glucos
use
induc
fab
express
purif
step
polymyxin
b
use
releas
fab
bacteri
periplasm
final
ninta
affin
chromatographi
use
specif
purifi
histag
fab
addit
use
mab
antivir
fab
serv
import
tool
specif
detect
reagent
variou
techniqu
enzymelink
immunosorb
assay
elisa
western
blot
immunoprecipit
flow
cytometri
analysi
research
purpos
often
conveni
express
purifi
fab
smaller
amount
howev
quit
often
quantiti
fab
insuffici
purpos
necess
rapid
method
express
purif
devis
rapid
method
first
stock
monoclon
recombin
phage
harbor
plasmid
phagemid
encod
desir
fab
prepar
phage
use
multipl
rapid
fab
express
purif
procedur
compet
cell
stratagen
san
diego
ca
plasmid
dna
phagemid
encod
fab
clone
select
specif
antigen
phage
librari
see
note
medium
gl
yeast
extract
bacto
voigt
global
distribut
gl
trypton
bacto
voigt
global
distribut
gl
nacl
deioniz
water
autoclav
store
room
temperatur
longer
month
supplement
agar
plate
gl
select
agar
invitrogen
carlsbad
ca
gl
glucos
medium
autoclav
medium
cool
solidifi
add
ampicillin
sigma
st
loui
mo
pour
ml
per
plate
bd
bioscienc
san
jose
ca
store
plate
longer
month
helper
phage
neb
ipswich
pegnacl
solut
vv
nacl
water
method
select
purif
fab
clone
plasmid
dna
pleas
refer
correspond
chapter
book
present
protocol
fab
clone
encod
phagemid
vector
pcomp
flag
tag
attach
fab
cterminu
e
coli
strain
store
supplement
express
medium
gl
yeast
extract
gl
trypton
gl
nacl
gl
glucos
deioniz
water
autoclav
add
ampicillin
store
longer
month
b
iptg
invitrogen
store
c
inocul
loop
fischer
scientif
pittsburgh
pa
nacl
stock
imidazol
sigma
stock
wash
buffer
nacl
mm
imidazol
pb
store
room
temperatur
elut
buffer
mm
imidazol
pb
store
room
temperatur
heat
shock
water
bath
cool
ice
min
add
soc
prewarm
place
shaker
rpm
hour
spread
supplement
agar
plate
incub
plate
overnight
pick
singl
coloni
transform
cell
grow
ml
medium
supplement
ampicilin
glucos
od
reach
usual
take
sever
hour
transform
bacteria
altern
perform
electropor
accord
protocol
stratagen
howev
avail
electropor
prepar
compet
cell
follow
inocul
cell
ml
see
grow
overnight
dilut
overnight
cultur
wild
type
bacteria
ml
fresh
medium
grow
bacteria
reach
optic
densiti
nm
keep
bacteria
ice
minimum
min
centrifug
centrifug
min
discard
supernat
resuspend
bacteri
pellet
ml
icecold
cacl
keep
ice
min
cell
must
remain
cold
time
treat
gentli
presenc
cacl
centrifug
min
discard
supernat
gentli
resuspend
pellet
ml
icecold
cacl
incub
ice
least
one
hour
use
transform
store
aliquot
later
use
add
helper
phage
multipl
infect
bacteria
incub
anoth
minut
